The chemistry of irreversible capture

Claude F. Meares

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The specific recognition and binding of biological molecules by antibodies is fundamentally important. Natural antibodies are multivalent, having at least two identical ligand-binding sites; this permits them to bind tightly at cell surfaces, which present multiple copies of their target ligands. Antibodies that bind to soluble monovalent ligands, such as most small molecules, do not share this multivalent advantage. Nor do engineered fragments of antibodies, such as single-chain Fv proteins or Fab fragments, which generally possess only a single ligand-binding site. Engineered monovalent antibody/ligand pairs that retain the binding specificity of the antibody, but do not dissociate, are promising components of new delivery systems. These are based on a combination of genetic manipulation of the protein and chemical synthesis of appropriate ligands, examples of which are reviewed here.

Original languageEnglish (US)
Pages (from-to)1383-1388
Number of pages6
JournalAdvanced Drug Delivery Reviews
Volume60
Issue number12
DOIs
StatePublished - Sep 15 2008

Fingerprint

Ligands
Antibodies
Binding Sites
Immunoglobulin Variable Region
Single-Chain Antibodies
Immunoglobulin Fragments
Immunoglobulin Fab Fragments
Antibody Specificity
Proteins

Keywords

  • Affinity label
  • Antibody
  • Bifunctional chelating agent
  • DOTA
  • Macrocycle
  • Mutagenesis
  • Protein engineering
  • Receptor

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

The chemistry of irreversible capture. / Meares, Claude F.

In: Advanced Drug Delivery Reviews, Vol. 60, No. 12, 15.09.2008, p. 1383-1388.

Research output: Contribution to journalArticle

Meares, Claude F. / The chemistry of irreversible capture. In: Advanced Drug Delivery Reviews. 2008 ; Vol. 60, No. 12. pp. 1383-1388.
@article{05ebcda6067247209b6ef58ff49dfcf1,
title = "The chemistry of irreversible capture",
abstract = "The specific recognition and binding of biological molecules by antibodies is fundamentally important. Natural antibodies are multivalent, having at least two identical ligand-binding sites; this permits them to bind tightly at cell surfaces, which present multiple copies of their target ligands. Antibodies that bind to soluble monovalent ligands, such as most small molecules, do not share this multivalent advantage. Nor do engineered fragments of antibodies, such as single-chain Fv proteins or Fab fragments, which generally possess only a single ligand-binding site. Engineered monovalent antibody/ligand pairs that retain the binding specificity of the antibody, but do not dissociate, are promising components of new delivery systems. These are based on a combination of genetic manipulation of the protein and chemical synthesis of appropriate ligands, examples of which are reviewed here.",
keywords = "Affinity label, Antibody, Bifunctional chelating agent, DOTA, Macrocycle, Mutagenesis, Protein engineering, Receptor",
author = "Meares, {Claude F.}",
year = "2008",
month = "9",
day = "15",
doi = "10.1016/j.addr.2008.04.010",
language = "English (US)",
volume = "60",
pages = "1383--1388",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - The chemistry of irreversible capture

AU - Meares, Claude F.

PY - 2008/9/15

Y1 - 2008/9/15

N2 - The specific recognition and binding of biological molecules by antibodies is fundamentally important. Natural antibodies are multivalent, having at least two identical ligand-binding sites; this permits them to bind tightly at cell surfaces, which present multiple copies of their target ligands. Antibodies that bind to soluble monovalent ligands, such as most small molecules, do not share this multivalent advantage. Nor do engineered fragments of antibodies, such as single-chain Fv proteins or Fab fragments, which generally possess only a single ligand-binding site. Engineered monovalent antibody/ligand pairs that retain the binding specificity of the antibody, but do not dissociate, are promising components of new delivery systems. These are based on a combination of genetic manipulation of the protein and chemical synthesis of appropriate ligands, examples of which are reviewed here.

AB - The specific recognition and binding of biological molecules by antibodies is fundamentally important. Natural antibodies are multivalent, having at least two identical ligand-binding sites; this permits them to bind tightly at cell surfaces, which present multiple copies of their target ligands. Antibodies that bind to soluble monovalent ligands, such as most small molecules, do not share this multivalent advantage. Nor do engineered fragments of antibodies, such as single-chain Fv proteins or Fab fragments, which generally possess only a single ligand-binding site. Engineered monovalent antibody/ligand pairs that retain the binding specificity of the antibody, but do not dissociate, are promising components of new delivery systems. These are based on a combination of genetic manipulation of the protein and chemical synthesis of appropriate ligands, examples of which are reviewed here.

KW - Affinity label

KW - Antibody

KW - Bifunctional chelating agent

KW - DOTA

KW - Macrocycle

KW - Mutagenesis

KW - Protein engineering

KW - Receptor

UR - http://www.scopus.com/inward/record.url?scp=46849112799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46849112799&partnerID=8YFLogxK

U2 - 10.1016/j.addr.2008.04.010

DO - 10.1016/j.addr.2008.04.010

M3 - Article

C2 - 18538444

AN - SCOPUS:46849112799

VL - 60

SP - 1383

EP - 1388

JO - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 12

ER -